Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Secondary Hemophagocytic Lymphohistiocytosis (sHLH) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2/3

NCT05416307

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

Hemophagocytic lymphohistiocytosis is a rare, aggressive and life-threatening syndrome of excessive immune activation. Secondary hemophagocytic lymphohistiocyto…

United States156 participantsStarted 2022-05-19

Treatment: ELA026

All recent trials (4 shown)

CompletedPhase 3

NCT04979884

Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital

The study to evaluate the effect of cyclosporine ( IL2 inhibitor and antiviral) verse standard care treatment on decrease ADRS, hyper inflammation, hypercytokin…

Egypt66 participantsStarted 2022-01-03

Treatment: cyclosporine

CompletedPhase 2

NCT03311854

A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile I…

Macrophage Activation Syndrome (MAS) is a rare, life-threatening condition characterized by uncontrolled hyperinflammation which may develop on the background o…

United States, France +3 more14 participantsStarted 2018-02-20

Treatment: Emapalumab

Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

All recent trials (4 shown)

Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital

A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile I…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

All recent trials (4 shown)

Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital

A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile I…

Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH